Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial.
Saved in:
| Title: | Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. |
|---|---|
| Authors: | Zisman-Ilani Y; Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia, Pennsylvania, USA.; Department of Clinical, Educational and Health Psychology, Division of Psychology and Language Sciences, University College London, London, UK., Thompson KD; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Siegel LS; Climate Interactive, Hanover, New Hampshire, USA., Mackenzie T; Geisel School of Medicine at Dartmouth, Biomedical Data Science, Hanover, New Hampshire, USA., Crate DJ; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Korzenik JR; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA., Melmed GY; Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Kozuch P; Inflammatory Bowel Disease Program, Jefferson University Hospitals, Philadelphia, Pennsylvania, USA., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Rubin DT; Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, Illinois, USA., Regueiro MD; Cleveland Clinic, Cleveland, Ohio, USA., Cross R; Department of Medicine, Division of Gastroenterology & Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Wolf DC; Atlanta Gastroenterology Associates, Atlanta, Georgia, USA., Hanson JS; Atrium Health Gastroenterology and Hepatology, Charlotte, North Carolina, USA., Schwartz RM; MNGI Digestive Health, Minneapolis, Minnesota, USA., Vrabie R; Gastroenterology Division, New York University, New York City, New York, USA., Kreines MD; Gastro Health, Cincinnati, Ohio, USA., Scherer T; Southern New Hampshire Health, Nashua, New Hampshire, USA., Dubinsky MC; Department of Pediatrics, Susan and Leonard Feinstein IBD Center, Icahn School of Medicine Mount Sinai, New York City, New York, USA., Siegel CA; Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jan; Vol. 57 (2), pp. 205-214. Date of Electronic Publication: 2022 Nov 14. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
